Previous close | 6.4500 |
Open | 1.2500 |
Bid | 1.0000 |
Ask | 1.6000 |
Strike | 480.00 |
Expiry date | 2024-07-19 |
Day's range | 1.2500 - 1.2500 |
Contract range | N/A |
Volume | |
Open interest | 22 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning